| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.03B | +4.4% |
| R&D Expense | $1.10B | -8.3% |
| SG&A Expense | $3.99B | -0.5% |
| Operating Income | $4.37B | +72.3% |
| Interest Expense | $621.0M | +13.9% |
| Pre-tax Income | $5.02B | +113.8% |
| Income Tax | $842.0M | +190.3% |
| Net Income | $4.17B | +103.0% |
| EPS (Basic) | $28.39 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.27B | -12.5% |
| Inventory | $1.46B | +31.2% |
| Current Assets | $14.27B | +4.1% |
| Total Assets | $49.36B | +6.0% |
| Current Liabilities | $14.13B | +18.3% |
| Long-term Debt | $16.27B | +17.5% |
| Total Liabilities | $34.07B | +7.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.39B | +13.2% |
| Capital Expenditures | $1.77B | -0.5% |
| Investing Cash Flow | -$1.75B | -10.6% |
| Financing Cash Flow | -$1.40B | +20.8% |
| Free Cash Flow | $2.62B | +24.8% |
| +109.2% |
| EPS (Diluted) | $28.34 | +109.5% |
| Stockholders' Equity |
| $15.29B |
| +3.3% |